Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-702-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 September 2015 to 08 October 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- Phenol, 1,1-dimethylpropyl derivs.
- IUPAC Name:
- Phenol, 1,1-dimethylpropyl derivs.
- Test material form:
- solid
- Details on test material:
- Identification: Phenol, 1,1-dimethylpropyl derivs.Appearance: Colourless to pale yellow solidBatch OP: C605E003.1Purity/Composition: 100% Unknown or Variable Composition, Complex Reaction Products and Biological Materials (UVCB)Test item storage: At room temperature protected from light container flushed with nitrogenStable under storage conditions until: 31 July 2016 (expiry date)Purity/composition correction factor: No correction factor requiredTest item handling: Use amber glassware or wrap container in aluminum-foil. To liquidify and homogenize: heat the test item until maximum 130°C under nitrogen.Stability at higher temperatures: Yes, maximum temperature: 130°C maximum duration: multiple hours if stored under nitrogen. If heated only minutesChemical name (IUPAC), synonym or trade name: Phenol, 1,1-dimethylpropyl derivs.CAS Number: 1639131-79-5
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Species: Rat, Wistar strain Crl:WI (Han) (outbred, SPF-Quality). Recognized by international guidelines as the recommended test system (e.g. OECD, EC). Source: Charles River Deutschland, Sulzfeld, Germany. Number of animals: 9 Females (nulliparous and non-pregnant). Each dose group consisted of 3 animals. Age and body weight: Young adult animals (approx. 8-12 weeks old) were selected. Body weight variation did not exceed +/- 20% of the sex mean. Identification: Earmark and tail mark Health inspection: At least prior to dosing. It was ensured that the animals were healthy and without any abnormality that might affect the study integrity. Animal husbandry Conditions: Environmental controls for the animal room were set to maintain 18 to 24°C, a relative humidity of 40 to 70%, at least 10 air changes/hour, and a 12-hour light/12-hour dark cycle: the photoperiod was between 07:00 and 19:00 hrs daily. Any variations to these conditions were maintained in the raw data and had no effect on the outcome of the study. Accommodation: Group housing of 3 animals per cage in labeled Makrolon cages (MIV type; height 18 cm.) containing sterilized sawdust as bedding material (Lignocel S 8-15, JRS - J.Rettenmaier & Söhne GmbH + CO. KG, Rosenberg, Germany) and paper as cage-enrichment (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom). Acclimatization period was at least 5 days before start of treatment under laboratory conditions. Diet: Free access to pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany). Water: Free access to tap water. Diet, water, bedding and cage enrichment evaluation for contaminants and/or nutrients was performed according to facility standard procedures. There were no findings that could interfere with the study.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- propylene glycol
- Details on oral exposure:
- Vehicle Rationale: Propylene glycol (Merck, Darmstadt, Germany) (specific gravity 1.036). The vehicle was selected based on trial preparations performed at WIL Research Europe and on test substance data supplied by the Sponsor. There was no information available regarding the solubility or stability in vehicle. Preparation: The preparations (w/w) were kept at room temperature protected from light and were dosed within 4 hours after adding the vehicle to the test substance. Homogeneity was assessed by visual inspection of the solutions and the formulations were stirred during dosing, which ensures homogeneity sufficient for these kinds of studies. Adjustment was made for specific gravity of the vehicle. No correction was made for purity of the test substance. The concentration of the test substance in vehicle was varied to allow constant dosage volume in terms of mL/kg body weight. Prior to weighing the test substance was heated in a water bath with a maximum temperature of 80.1°C for a maximum of 3 hours and 15 minutes. In order to obtain homogeneity, the test substance (preparations) were heated in a water bath with a maximum temperature of 81.3 ºC for a maximum of 15 minutes. The test substance (formulations) were allowed to cool to a temperature of maximally 40°C prior to dosing.Study design The toxicity of the test substance was assessed by stepwise treatment of groups of 3 females. The first group was treated at a dose level of 2000 mg/kg. The absence or presence of mortality of animals dosed at one step determined the next step, based on the test procedure defined in the guidelines. The onset, duration and severity of the signs of toxicity were taken into account for determination of the time interval between the dose groups.
- Doses:
- 2000 mg/kg (10 mL/kg) body weight.300 mg/kg (10 mL/kg) body weight.
- No. of animals per sex per dose:
- Groups of 3 females.
- Control animals:
- no
- Details on study design:
- Treatment Method: Oral gavage, using plastic feeding tubes. The test item preparations were stirred on a magnetic stirrer during dosing. Fasting: Animals were deprived of food overnight prior to dosing and until 3-4 hours after administration of the test substance. Water was available ad libitum. Frequency: Single dosage on Day 1. Dose level (volume): 2000 mg/kg (10 mL/kg) body weight. 300 mg/kg (10 mL/kg) body weight. Observations Mortality/Viability: Twice daily. The time of death was recorded as precisely as possible. Body weights: Days 1 (pre-administration), 8 and 15 and at death (if found dead after Day 1). Clinical signs: At periodic intervals on the day of dosing (Day 1) and once daily thereafter, until Day 15. The signs were graded according to fixed scales and the time of onset, degree and duration were recorded: Maximum grade 4: grading slight (1) to very severe (4) Maximum grade 3: grading slight (1) to severe (3) Maximum grade 1: presence is scored (1). Necropsy: The animals surviving to the end of the observation period were sacrificed by oxygen/carbon dioxide procedure. All animals assigned to the study were subjected to necropsy and descriptions of all internal macroscopic abnormalities recorded.
- Statistics:
- No statistical analysis was performed (The method used is not intended to allow the calculation of a precise LD50 value).
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- female
- Dose descriptor:
- LD50 cut-off
- Effect level:
- 500 mg/kg bw
- Based on:
- test mat.
- Sex:
- female
- Dose descriptor:
- approximate LD50
- Effect level:
- >= 300 - <= 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- At 2000 mg/kg, all animals died, one animal was found dead on Day 2 and two animals were found dead on Day 5.At 300 mg/kg, no mortality occurred.
- Clinical signs:
- other: At 2000 mg/kg, lethargy, flat posture, hunched posture, uncoordinated movements, slow breathing, shallow respiration, piloerection, watery discharge from left eye, pale appearance, lean appearance, hypothermia and/or ptosis were noted for the animals betw
- Gross pathology:
- At 2000 mg/kg, abnormalities of the stomach (irregular surface), gastrointestinal-tract (distended with gas, contents: gelatinous, yellowish) and/or thymus (reduced in size) were found in the animals that died during the study, at macroscopic post mortem examination.At 300 mg/kg, abnormalities of the stomach (irregular surface) were found in three animals at macroscopic examination.Autolysis was noted for two of the animals found dead.
- Other findings:
- No further information specified in the study report.
Any other information on results incl. tables
MORTALITY DATA
TEST DAY |
1 |
1 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
HOURS AFTER TREATMENT |
0 |
2 |
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FEMALES 2000 MG/KG FEMALES 300 MG/KG FEMALES 300 MG/KG |
- - - |
- - - |
- - - |
1 - - |
- - - |
- - - |
2 - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
CLINICAL SIGNS
TEST DAY |
MAX GRADE |
1 |
1 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
HOURS AFTER TREATMENT |
0 |
2 |
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FEMALES 2000 MG/KG |
||||||||||||||||||
ANIMAL 1 Behaviour -Lethargy Posture -Hunched posture Gait/Motility -Uncoordinated movements Skin/Fur -Piloerection Various -Ptosis |
(3)
(1)
(3)
(1)
(3) |
-
1
-
1
- |
1
1
2
1
1 |
1
1
2
1
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ANIMAL 2 Behaviour -Lethargy Posture -Hunched posture Gait/Motility -Uncoordinated movements Skin/Fur -Piloerection Various -Pale -Lean -Ptosis -Hypothermia |
(3)
(1)
(3)
(1)
(3) (1) (3) (1) |
-
1
-
1
- - - - |
1
1
1
1
- - 1 - |
1
1
1
1
- - 1 - |
-
1
1
1
- - - - |
-
1
1
1
- - - - |
1
1
1
1
1 1 - 1 |
|
|
|
|
|
|
|
|
|
|
|
ANIMAL 3 Behaviour -Lethargy Posture -Flat posture -Hunched posture Gait/Motility -Uncoordinated movements Breathing -Slow breathing -Shallow respiration Skin/Fur -Piloerection Secretion/Excretion -Watery discharge from eye (Eye left) Various -Pale -Lean -Ptosis -Hypothermia |
(3)
(1) (1)
(3)
(1) (3)
(1)
(3)
(3) (1) (3) (1) |
-
- 1
-
- -
1
-
- - - - |
2
1 -
-
1 1
1
1
- - 1 - |
1
- -
-
1 1
1
1
- - 1 - |
-
- 1
1
- -
1
-
- - - - |
-
- 1
1
- -
1
-
- - - - |
1
- 1
1
- -
1
-
1 1 - 1 |
|
|
|
|
|
|
|
|
|
|
|
FEMALES 300 MG/KG |
||||||||||||||||||
ANIMAL 4 Behaviour -Lethargy Posture -Flat posture -Hunched posture Gait/Motility -Uncoordinated movement Breathing -Shallow respiration Skin/Fur -Piloerection |
(3)
(1) (1)
(3)
(3)
(1) |
-
- 1
-
-
- |
1
- 1
1
1
1 |
1
1 1
1
1
1 |
-
- 1
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
-
- -
-
-
- |
ANIMAL 5 Behaviour -Lethargy Posture -Flat posture -Hunched posture Gait/Motility -Uncoordinated movement Breathing -Shallow respiration Skin/Fur -Piloerection Various -Ptosis |
(3)
(1) (1)
(3)
(3)
(1)
(3) |
-
- 1
-
-
-
- |
1
- 1
1
1
1
1 |
1
1 1
1
1
1
1 |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
-
- -
-
-
-
- |
ANIMAL 6 Behaviour -Lethargy Posture -Flat posture -Hunched posture Gait/Motility -Uncoordinated movement Breathing -Shallow respiration Skin/Fur -Piloerection Secretion/Excretion -Diarrhoea Various -Ptosis |
(3)
(1) (1)
(3)
(3)
(1)
(1)
(3) |
-
- 1
-
-
-
-
- |
1
- 1
1
1
1
1
1 |
1
1 1
1
1
1
1
1 |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
-
- -
-
-
-
-
- |
FEMALES 300 MG/KG |
||||||||||||||||||
ANIMAL 7 Behaviour -Lethargy Posture -Hunched posture Gait/Motility -Uncoordinated movements Skin/Fur -Piloerection |
(3)
(1)
(3)
(1) |
-
1
-
- |
-
1
1
- |
1
1
1
1 |
-
1
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
ANIMAL 8 Posture -Hunched posture Gait/Motility -Uncoordinated movements Skin/Fur -Piloerection |
(1)
(3)
(1) |
1
-
- |
1
1
- |
1
1
1 |
1
-
- |
-
-
- |
-
-
- |
-
-
- |
-
-
- |
-
-
- |
-
-
- |
-
-
- |
-
-
- |
-
-
- |
-
-
- |
-
-
- |
-
-
- |
-
-
- |
ANIMAL 9 Behaviour -Lethargy Posture -Hunched posture Gait/Motility -Uncoordinated movements Skin/Fur -Piloerection |
(3)
(1)
(3)
(1) |
-
1
-
- |
-
1
1
- |
1
1
1
1 |
-
1
-
- |
-
1
-
- |
-
1
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
-
-
-
- |
- = Sign not observed
BODY WEIGHTS (GRAM)
SEX/DOSE LEVEL |
ANIMAL |
DAY 1 |
DAY 8 |
DAY 15 |
FEMALES 2000 MG/KG |
1 2 3
MEAN ST. DEV. N |
198* 201** 184**
194 9 3 |
- - -
- - 0 |
- - -
- - 0 |
FEMALES 300 MG/KG |
4 5 6
MEAN ST. DEV. N |
182 179 165
175 9 3 |
206 194 177
192 15 3 |
216 204 188
203 14 3 |
FEMALES 300 MG/KG |
7 8 9
MEAN ST. DEV. N |
152 146 165
154 10 3 |
174 168 193
178 13 3 |
197 186 206
196 10 3 |
* Animal found dead on Day 2. Body weight at death: 191 gram.
** Animals found dead on Day 5. Body weights at death: 159 and 150 gram, respectively.
MACROSCOPIC FINDINGS
ANIMAL |
ORGAN |
FINDING |
DAY OF DEATH |
FEMALES 2000 MG/KG |
|||
1 |
General observations
Stomach |
GI-tract: contents: gelatinous GI-tract: contents: yellowish Forestomach: irregular surface |
Spontaneous death Day 2 after treatment |
2 |
General observations |
Advanced autolysis GI-tract: contents: yellowish |
Spontaneous death Day 5 after treatment |
3 |
General observations
Stomach Thymus |
GI-tract: [distended with gas] Advanced autolysis Forestomach: irregular surface Reduced in size |
Spontaneous death Day 5 after treatment |
FEMALES 300 MG/KG |
|||
4 |
Stomach |
Forestomach: irregular surface |
Scheduled necropsy Day 15 after treatment |
5 |
Stomach |
Forestomach: irregular surface |
Scheduled necropsy Day 15 after treatment |
6 |
Stomach |
Forestomach: irregular surface |
Scheduled necropsy Day 15 after treatment |
FEMALES 300 MG/KG |
|||
7 |
|
No findings noted |
Scheduled necropsy Day 15 after treatment |
8 |
|
No findings noted |
Scheduled necropsy Day 15 after treatment |
9 |
|
No findings noted |
Scheduled necropsy Day 15 after treatment |
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The oral LD50 value of Phenol, 1,1-dimethylpropyl derivs. in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.According to the OECD 423 test guideline, the LD50 cut-off value was considered to 500 mg/kg body weight.Based on these results:- according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2011) (including all amendments), Phenol, 1,1-dimethylpropyl derivs. should be classified as: harmful if swallowed (Category 4) for acute toxicity by the oral route;- according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (including all amendments), Phenol, 1,1-dimethylpropyl derivs. should be classified as Category 4 and should be labeled as H302: Harmful if swallowed.
- Executive summary:
Assessment of acute oral toxicity with Phenol, 1,1-dimethylpropyl derivs. in the rat (Acute Toxic Class Method).
The study was carried out based on the guidelines described in:
OECD No.423 (2001) "Acute Oral Toxicity, Acute Toxic Class Method"
Commission Regulation (EC) No 440/2008, B1 tris: "Acute Oral Toxicity, Acute Toxic Class Method"
EPA, OPPTS 870.1100 (2002), "Acute Oral Toxicity"
JMAFF Guidelines (2000), including the most recent revisions.
Initially, Phenol, 1,1-dimethylpropyl derivs. was administered by oral gavage to three female Wistar rats at 2000 mg/kg body weight. In a stepwise procedure two additional groups of three females were dosed at 300 mg/kg body weight. The animals were subjected to daily observations and weekly determination of body weight. Macroscopic examination was performed on the day of death or after terminal sacrifice (Day 15).
At 2000 mg/kg, all animals died, one animal was found dead on Day 2 and two animals were found dead on Day 5.
At 300 mg/kg, no mortality occurred.
At 2000 mg/kg, lethargy, flat posture, hunched posture, uncoordinated movements, slow breathing, shallow respiration, piloerection, watery discharge from left eye, pale appearance, lean appearance, hypothermia and/or ptosis were noted for the animals between Days 1 and 5.
At 300 mg/kg, lethargy, flat posture, hunched posture, uncoordinated movements, shallow respiration, piloerection, ptosis and/or diarrhoea were noted for the animals on Days 1 and/or 2. Additionally, hunched posture was noted for one animal on Days 3 and 4.
The body weight gain shown by the surviving animals over the study period was considered to be similar to that expected for normal untreated animals of the same age and strain.
At 2000 mg/kg, abnormalities of the stomach (irregular surface), gastrointestinal-tract (distended with gas, contents: gelatinous, yellowish) and/or thymus (reduced in size) were found in the animals that died during the study, at macroscopic post mortem examination.
At 300 mg/kg, abnormalities of the stomach (irregular surface) were found in three animals at macroscopic examination.
The oral LD50 value of Phenol, 1,1-dimethylpropyl derivs. in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.
According to the OECD 423 test guideline, the LD50 cut-off value was considered to 500 mg/kg body weight.
Based on these results:
- according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2011) (including all amendments), Phenol, 1,1-dimethylpropyl derivs. should be classified as: harmful if swallowed (Category 4) for acute toxicity by the oral route;
- according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (including all amendments), Phenol, 1,1-dimethylpropyl derivs. should be classified as Category 4 and should be labelled as H302: Harmful if swallowed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.